Bioindustries Call News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioindustries call. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioindustries Call Today - Breaking & Trending Today

ARM, EFPIA and EuropaBio Call for Advanced Therapies to be Exempt from EU GMO Legislation

ARM, EFPIA and EuropaBio Call for Advanced Therapies to be Exempt from EU GMO Legislation
Alliance for Regenerative Medicine, European Federation of Pharmaceutical Industries and Associations, and European Association for Bioindustries Call for
Advanced Therapies
needs
patients
, 2021
The European Commission should exempt advanced therapies from Genetically Modified Organism (GMO) legislation, which hurts Europe’s ability to attract clinical trials and delays patient access to transformative medicines, said the Alliance for Regenerative Medicine (ARM), the European Federation of Pharmaceutical Industries and Associations (EFPIA), and the European Association of Bioindustries (EuropaBio) in a paper published online yesterday in the journal
Human Gene Therapy. ....

United States , Bruxelles Capitale , Andy Powrie Smith , Paige Bischoff , Violeta Georgieva , Dovile Sandaraite , European Association Of Bioindustries Europabio , Regulatory Affairs , European Commission , European Federation Of Pharmaceutical Industries , Europabio Legal Affairs Manager , Eu Court , Global Public Affairs , Alliance For Regenerative Medicine , Regenerative Medicine , European Federation , Pharmaceutical Industries , European Association , Bioindustries Call , Advanced Therapiesto , Genetically Modified Organism , Human Gene , Advanced Therapy Medicinal Products , Vice President , Global Public , Pharmaceutical Strategy ,

The Alliance for Regenerative Medicine: ARM, EFPIA and EuropaBio Call for Advanced Therapies to be Exempt from EU GMO Legislation

The Alliance for Regenerative Medicine: ARM, EFPIA and EuropaBio Call for Advanced Therapies to be Exempt from EU GMO Legislation
Advanced Therapies
needs
patients
, 2021
Human Gene Therapy.
The European Commission recognized that GMO requirements hinder the conduct of clinical trials in its April 29 study on new genomic techniques and in the 2020 Pharmaceutical Strategy for Europe, when it called for GMO legislation to be fit for purpose for addressing medicines. The original GMO legislation was primarily enacted to protect food consumers and the environment, but Advanced Therapy Medicinal Products (ATMPs) such as gene therapies are affected as an unintended consequence. The uneven application of GMO requirements across EU Member States causes significant clinical trial delays despite findings that gene therapies pose a negligible risk to the environment. ....

United States , Bruxelles Capitale , Kostenloser Wertpapierhandel , Andy Powrie Smith , Paige Bischoff , Violeta Georgieva , Dovile Sandaraite , Regulatory Affairs , European Association For Bioindustries , European Commission , European Federation Of Pharmaceutical Industries , Europabio Legal Affairs Manager , Eu Court , European Association For Bioindustries Europabio , Global Public Affairs , Alliance For Regenerative Medicine , Regenerative Medicine , European Federation , Pharmaceutical Industries , European Association , Bioindustries Call , Advanced Therapiesto , Genetically Modified Organismpublished , Human Gene , Advanced Therapy Medicinal Products , Vice President ,